BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 31061250)

  • 1. Therapy-related Secondary Malignancy After Treatment of Childhood Malignancy: Cases from a Single Center.
    Ueda T; Migita M; Itabashi T; Tanabe Y; Uchimura R; Gocho Y; Yamanishi M; Kobayashi F; Yoshino M; Fujita A; Yamanishi S; Kaizu K; Hayakawa J; Asano T; Maeda M; Itoh Y
    J Nippon Med Sch; 2019 Sep; 86(4):207-214. PubMed ID: 31061250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Second malignancies after Ewing's sarcoma: radiation dose-dependency of secondary sarcomas.
    Kuttesch JF; Wexler LH; Marcus RB; Fairclough D; Weaver-McClure L; White M; Mao L; Delaney TF; Pratt CB; Horowitz ME; Kun LE
    J Clin Oncol; 1996 Oct; 14(10):2818-25. PubMed ID: 8874344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High incidence of meningioma in cranial irradiated survivors of childhood acute lymphoblastic leukemia.
    Goshen Y; Stark B; Kornreich L; Michowiz S; Feinmesser M; Yaniv I
    Pediatr Blood Cancer; 2007 Sep; 49(3):294-7. PubMed ID: 17243137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cumulative incidence of secondary neoplasms as a first event after childhood acute lymphoblastic leukemia.
    Hijiya N; Hudson MM; Lensing S; Zacher M; Onciu M; Behm FG; Razzouk BI; Ribeiro RC; Rubnitz JE; Sandlund JT; Rivera GK; Evans WE; Relling MV; Pui CH
    JAMA; 2007 Mar; 297(11):1207-15. PubMed ID: 17374815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Secondary Acute Leukemia in Sarcoma Patients: A Population-Based Study.
    Sanford NN; Martin AM; Brunner AM; Cote GM; Choy E; DeLaney TF; Aizer AA; Chen YL
    Int J Radiat Oncol Biol Phys; 2018 Mar; 100(3):687-694. PubMed ID: 29413281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Longitudinal follow-up of adult survivors of Ewing sarcoma: A report from the Childhood Cancer Survivor Study.
    Marina NM; Liu Q; Donaldson SS; Sklar CA; Armstrong GT; Oeffinger KC; Leisenring WM; Ginsberg JP; Henderson TO; Neglia JP; Stovall MA; Yasui Y; Randall RL; Geller DS; Robison LL; Ness KK
    Cancer; 2017 Jul; 123(13):2551-2560. PubMed ID: 28222219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Childhood ALL and second neoplasms.
    Maniar TN; Braunstein I; Keefe S; Hussen S; Abrams T; De Michele A; El-Deiry WS
    Cancer Biol Ther; 2007 Oct; 6(10):1525-31. PubMed ID: 17952026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Secondary hematopoietic malignancies in survivors of childhood cancer: an analysis of 111 cases from the Surveillance, Epidemiology, and End Result-9 registry.
    Rihani R; Bazzeh F; Faqih N; Sultan I
    Cancer; 2010 Sep; 116(18):4385-94. PubMed ID: 20549819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiation-induced meningiomas: a shadow in the success story of childhood leukemia.
    Banerjee J; Pääkkö E; Harila M; Herva R; Tuominen J; Koivula A; Lanning M; Harila-Saari A
    Neuro Oncol; 2009 Oct; 11(5):543-9. PubMed ID: 19179425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Second malignancies after treatment for Ewing's sarcoma: a report of the CESS-studies.
    Dunst J; Ahrens S; Paulussen M; Rübe C; Winkelmann W; Zoubek A; Harms D; Jürgens H
    Int J Radiat Oncol Biol Phys; 1998 Sep; 42(2):379-84. PubMed ID: 9788419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of Meningioma in European Patients Treated With Growth Hormone in Childhood: Results From the SAGhE Cohort.
    Swerdlow AJ; Cooke R; Beckers D; Butler G; Carel JC; Cianfarani S; Clayton P; Coste J; Deodati A; Ecosse E; Hokken-Koelega ACS; Khan AJ; Kiess W; Kuehni CE; Flück CE; Pfaffle R; Sävendahl L; Sommer G; Thomas M; Tidblad A; Tollerfield S; Zandwijken GRJ
    J Clin Endocrinol Metab; 2019 Mar; 104(3):658-664. PubMed ID: 30137467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Second Malignant Neoplasms in Childhood Cancer Survivors Treated in a Tertiary Paediatric Oncology Centre.
    Lim JW; Yeap FS; Chan YH; Yeoh AE; Quah TC; Tan PL
    Ann Acad Med Singap; 2017 Jan; 46(1):11-19. PubMed ID: 28182813
    [No Abstract]   [Full Text] [Related]  

  • 13. Morbidity and Mortality Associated With Meningioma After Cranial Radiotherapy: A Report From the Childhood Cancer Survivor Study.
    Bowers DC; Moskowitz CS; Chou JF; Mazewski CM; Neglia JP; Armstrong GT; Leisenring WM; Robison LL; Oeffinger KC
    J Clin Oncol; 2017 May; 35(14):1570-1576. PubMed ID: 28339329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of benign meningioma after childhood cancer in the DCOG-LATER cohort: contributions of radiation dose, exposed cranial volume, and age.
    Kok JL; Teepen JC; van Leeuwen FE; Tissing WJE; Neggers SJCMM; van der Pal HJ; Loonen JJ; Bresters D; Versluys B; van den Heuvel-Eibrink MM; van Dulmen-den Broeder E; van der Heiden-van der Loo M; Aleman BMP; Daniels LA; Haasbeek CJA; Hoeben B; Janssens GO; Maduro JH; Oldenburger F; van Rij C; Tersteeg RJHA; Hauptmann M; ; Kremer LCM; Ronckers CM
    Neuro Oncol; 2019 Feb; 21(3):392-403. PubMed ID: 30099534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of subsequent malignancies in survivors of childhood leukemia.
    Perkins SM; Dewees T; Shinohara ET; Reddy MM; Frangoul H
    J Cancer Surviv; 2013 Dec; 7(4):544-50. PubMed ID: 23749687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Second malignant neoplasms after treatment of childhood acute lymphoblastic leukemia.
    Schmiegelow K; Levinsen MF; Attarbaschi A; Baruchel A; Devidas M; Escherich G; Gibson B; Heydrich C; Horibe K; Ishida Y; Liang DC; Locatelli F; Michel G; Pieters R; Piette C; Pui CH; Raimondi S; Silverman L; Stanulla M; Stark B; Winick N; Valsecchi MG
    J Clin Oncol; 2013 Jul; 31(19):2469-76. PubMed ID: 23690411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Temporal Trends in Treatment and Subsequent Neoplasm Risk Among 5-Year Survivors of Childhood Cancer, 1970-2015.
    Turcotte LM; Liu Q; Yasui Y; Arnold MA; Hammond S; Howell RM; Smith SA; Weathers RE; Henderson TO; Gibson TM; Leisenring W; Armstrong GT; Robison LL; Neglia JP
    JAMA; 2017 Feb; 317(8):814-824. PubMed ID: 28245323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-Term Risk of Subsequent Malignant Neoplasms After Treatment of Childhood Cancer in the DCOG LATER Study Cohort: Role of Chemotherapy.
    Teepen JC; van Leeuwen FE; Tissing WJ; van Dulmen-den Broeder E; van den Heuvel-Eibrink MM; van der Pal HJ; Loonen JJ; Bresters D; Versluys B; Neggers SJCMM; Jaspers MWM; Hauptmann M; van der Heiden-van der Loo M; Visser O; Kremer LCM; Ronckers CM;
    J Clin Oncol; 2017 Jul; 35(20):2288-2298. PubMed ID: 28530852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Second malignancy after treatment of childhood non-Hodgkin lymphoma.
    Leung W; Sandlund JT; Hudson MM; Zhou Y; Hancock ML; Zhu Y; Ribeiro RC; Rubnitz JE; Kun LE; Razzouk B; Evans WE; Pui CH
    Cancer; 2001 Oct; 92(7):1959-66. PubMed ID: 11745271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Second cancers in long-term survivors of Ewing's sarcoma.
    Smith LM; Cox RS; Donaldson SS
    Clin Orthop Relat Res; 1992 Jan; (274):275-81. PubMed ID: 1729013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.